McClarren Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

McClarren Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-185	Closed	-$77K	–	179
2025 Q1	$77K	Hold	185	–	–	0.05%	115
2024 Q4	$76K	Hold	185	–	–	0.21%	63
2024 Q3	$93K	Sell	185 -302	-62%	-$147K	0.01%	96
2024 Q2	$90K	Buy	487 +302	+163%	+$152K	0.06%	111
2024 Q1	$100K	Hold	185	–	–	0.07%	104
2023 Q4	$103K	Hold	185	–	–	0.08%	106
2023 Q3	$80K	Hold	185	–	–	0.07%	117
2023 Q2	$92K	Hold	185	–	–	0.08%	110
2023 Q1	$92K	Hold	185	–	–	0.08%	105
2022 Q4	$75K	Hold	185	–	–	0.07%	118
2022 Q3	$60K	Buy	+185	New	+$68K	0.06%	115
2022 Q2	–	Sell	-185	Closed	-$101K	–	129
2022 Q1	$101K	Hold	185	–	–	0.07%	87
2021 Q4	$122K	Hold	185	–	–	0.08%	89
2021 Q3	$115K	Hold	185	–	–	0.09%	73
2021 Q2	$116K	Hold	185	–	–	0.09%	73
2021 Q1	$91K	Hold	185	–	–	0.08%	83
2020 Q4	$92K	Buy	+185	New	+$82.8K	0.09%	78

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

McClarren Financial Advisors's IDXX Position: Q2 2025 in Review

McClarren Financial Advisors sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 185 shares — an estimated $77K sold.

McClarren Financial Advisors first reported a position in IDXX in Q4 2020 and held it in 17 quarters. The position peaked at $122K in Q4 2021. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

McClarren Financial Advisors reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
McClarren Financial Advisors sold 185 Idexx Laboratories shares in Q2 2025, an estimated $77K.
McClarren Financial Advisors first reported a position in Idexx Laboratories in Q4 2020 and held it in 17 quarters.
McClarren Financial Advisors's Idexx Laboratories position peaked at $122K in Q4 2021.
1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on McClarren Financial Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.